24/7 customer support+44 (0) 345 676 9733
Lavender Medical, 646 Blackhorse Road, Letchworth Garden City, SG6 1HD

MaioRegen is a bio-inspired, resorbable scaffold that regenerates both bone and cartilage, restoring the physiology of the joint. Unlike treatments that address only the cartilage surface, it also treats the subchondral bone beneath it.

Made from collagen and magnesium-enriched hydroxyapatite by a patented process, MaioRegen mimics the chemistry and structure of the osteochondral unit in three layers: cartilage; calcified cartilage and subchondral bone; and spongy bone.

  • Ready to use, for a one-step procedure
  • Cell-free: colonised by the patient’s own cells
  • Fully resorbable as new tissue remodels
  • Supplied sterile, in single packs
  • Three thicknesses (Prime, Slim and Chondro+) in five sizes each

Indications

Cartilage and osteochondral lesions of the joint surface, whether traumatic, post-traumatic, degenerative or due to osteochondritis dissecans, in the knee and ankle.

  • MaioRegen Prime (0.6 cm): osteochondral lesions with severe subchondral involvement, including ICRS IVa/IVb, Outerbridge IV, early osteoarthritis (Kellgren-Lawrence I-II, no osteophytes) and osteochondritis dissecans.
  • MaioRegen Slim (0.4 cm): osteochondral lesions with moderate subchondral involvement, including ICRS IVa, Outerbridge IV and early osteoarthritis (Kellgren-Lawrence I-II, no osteophytes).
  • MaioRegen Chondro+ (0.2 cm): cartilage lesions with no or mild subchondral change, including ICRS III and Outerbridge III-IV.

How it works

  1. Prepare the site. Damaged tissue is removed, opening the lesion to blood flow from the subchondral bone.
  2. Implant. MaioRegen is fitted into the defect, restoring the anatomy of the joint surface.
  3. Colonise. Its porous structure and chemistry draw in bone-marrow-derived cells, which populate the scaffold.
  4. Regenerate. The cells form cartilage or bone according to each layer, while the scaffold is resorbed as new tissue remodels.

Clinical evidence

Finceramica reports that more than 7,000 patients have been treated with MaioRegen.

A level 1 randomised controlled trial comparing MaioRegen with microfracture (Kon et al.) reported statistically significant improvements in IKDC subjective, Tegner, KOOS and VAS scores at two years, with the largest differences in deep osteochondral lesions and in sport-active patients.

Recent publications include a 10-year follow-up in unicompartmental knee osteoarthritis (Solaro 2024) and a systematic review in the talus (Kolar 2022). Clinical summaries are available above.

Sizes and ordering

MaioRegen Prime (0.6 cm thick)
  • 01600288: 2.0 x 3.0 cm
  • 01600286: 3.0 x 4.0 cm
  • 01600285: Ø 1.2 cm
  • 01600275: Ø 1.5 cm
  • 01600291: Ø 1.8 cm
MaioRegen Slim (0.4 cm thick)
  • 01600289: 2.0 x 3.0 cm
  • 01600287: 3.0 x 4.0 cm
  • 01600290: Ø 1.2 cm
  • 01600282: Ø 1.5 cm
  • 01600292: Ø 1.8 cm
MaioRegen Chondro+ (0.2 cm thick)
  • 01600401: 2.0 x 3.0 cm
  • 01600400: 3.0 x 4.0 cm
  • 01600403: Ø 1.2 cm
  • 01600405: Ø 1.5 cm
  • 01600404: Ø 1.8 cm
Instruments

MaioRegen Mini-Arthro Kit (33109), for arthroscopic implantation.

Talk to us about orthopaedic implants and materials

Contact UsOur Products

Our Ethos

  • The highest standard of service, every time
  • High-quality, innovative products for UK surgeons
  • Genuine value for money
  • Working alongside our customers to give patients the best care
  • Teamwork and integrity in every relationship

Search